Patent · US Active

Pyrimidine carboxamides as sodium channel blockers

US9637458B2 · kind B2 · utility

2Cited by
25References
19Claims
0Family size

Inventors

Key dates

Filing dateMar 3, 2014
Grant dateMay 2, 2017
Priority date
Expiry dateMar 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides substituted pyrimidine carboxamides of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein A1, X, A2, W1, W2, W3, E, Z, and R4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.